COLUMBUS CIRCLE INVESTORS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$8,071,000
-41.0%
80,990
-32.0%
0.44%
-24.5%
Q4 2019$13,687,000
+16.4%
119,122
+27.8%
0.59%
+36.1%
Q3 2019$11,759,000
+29.9%
93,224
+23.9%
0.43%
+78.5%
Q2 2019$9,054,000
-63.4%
75,234
-69.6%
0.24%
-65.5%
Q4 2018$24,744,000
-28.4%
247,320
-18.0%
0.70%
+1.6%
Q3 2018$34,575,000
+47.9%
301,752
+15.8%
0.69%
+42.9%
Q2 2018$23,378,000
+60.3%
260,678
+30.8%
0.48%
+63.2%
Q1 2018$14,581,000199,3030.30%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders